These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10588204)

  • 1. Frequency of major adverse cardiac events within one month of coronary angioplasty: a useful measure of operator performance.
    Lindsay J; Pinnow EE; Pichard AD
    J Am Coll Cardiol; 1999 Dec; 34(7):1916-23. PubMed ID: 10588204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of percutaneous coronary angioplasty (PTCA) performed in a low-volume institution by low-volume operators, evaluated by means of the one-month major adverse cardiac event rate.
    Rubboli A; Brancaleoni R; Euler DE; Casella G; La Vecchia L; Fontanelli A; Sangiorgio P; Bracchetti D
    Minerva Cardioangiol; 2001 Dec; 49(6):357-62. PubMed ID: 11733729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operator experience and long term outcome after percutaneous coronary intervention.
    Mueller C; Hodgson JM; Brutsche M; Bestehorn HP; Marsch S; Perruchoud AP; Roskamm H; Buettner HJ
    Can J Cardiol; 2003 Aug; 19(9):1047-51. PubMed ID: 12915932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
    Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP
    J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EuroSCORE is a good global predictor of long-term outcomes in high-risk but not in low-risk patients after unprotected left main angioplasty.
    Rekik S; Brunet J; Bayet G; Hager FX; Meille L; Quatre JM; Sainsous J
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):625-32. PubMed ID: 20578163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators.
    Gyöngyösi M; Yang P; Khorsand A; Glogar D
    J Am Coll Cardiol; 2000 May; 35(6):1580-9. PubMed ID: 10807464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benchmarking operator performance in percutaneous coronary intervention: a novel approach using 30-day events.
    Lindsay J; Pinnow EE; Pichard AD
    Catheter Cardiovasc Interv; 2001 Feb; 52(2):139-45; discussion 146. PubMed ID: 11170317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery [the ROSETTA (Routine versus Selective Exercise Treadmill Testing after Angioplasty) Registry].
    Garzon P; Sheppard R; Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Mak KH; Brown DL;
    Am J Cardiol; 2002 Feb; 89(3):251-6. PubMed ID: 11809424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary angioplasty and routine utilization of thrombus aspiration devices: feasibility and results in a consecutive series of 486 patients.
    Varbella F; Gagnor A; Luceri S; Bongioanni S; Nannini C; Masi AS; Tripodi R; Pron PG; Mainardi L; Badalì A; Conte MR
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):258-64. PubMed ID: 17413302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of coronary artery stenting in women versus men: a single center experience.
    Moriel M; Feld S; Almagor Y; Balkin JA; Klutstein MW; Meerkin D; Rosenmann D; Winkler H; Tzivoni D
    Isr Med Assoc J; 2003 Jun; 5(6):398-402. PubMed ID: 12841008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database.
    Moscucci M; Share D; Smith D; O'Donnell MJ; Riba A; McNamara R; Lalonde T; Defranco AC; Patel K; Kline Rogers E; D'Haem C; Karve M; Eagle KA
    J Am Coll Cardiol; 2005 Aug; 46(4):625-32. PubMed ID: 16098426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.
    Morishima I; Sone T; Okumura K; Tsuboi H; Kondo J; Mukawa H; Matsui H; Toki Y; Ito T; Hayakawa T
    J Am Coll Cardiol; 2000 Oct; 36(4):1202-9. PubMed ID: 11028471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes.
    George BS; Voorhees WD; Roubin GS; Fearnot NE; Pinkerton CA; Raizner AE; King SB; Holmes DR; Topol EJ; Kereiakes DJ
    J Am Coll Cardiol; 1993 Jul; 22(1):135-43. PubMed ID: 8509533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome?
    Klein LW; Schaer GL; Calvin JE; Palvas B; Allen J; Loew J; Uretz E; Parrillo JE
    J Am Coll Cardiol; 1997 Oct; 30(4):870-7. PubMed ID: 9316511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
    Beeres SL; Oemrawsingh PV; Warda HM; Bechan R; Atsma DE; Jukema JW; van der Wall EE; Schalij MJ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):478-83. PubMed ID: 15973655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.